Analyzing our results of EZH2 expression in pediatric patients with MDS, it is also possible to suggest the dual role of EZH2 and this result has clinical implications, regarding the evolution of disease and also to aid the choice of the treatment, reinforcing the importance of incorporate additional laboratory tests to analyze the EZH2 expression. This evidence concerns the gene EZH2 and myelodysplastic syndrome.